BLRX
Biolinerx
$2.82
−$0.00 (−0.11%)Jul 27, 2026
Key metrics
The numbers that frame BLRX today
- Market cap
- $14.71M
- P/E (TTM)
- -1.7
- EV / FCF
- -0.8
- Gross margin
- 79.2%
- EV / Sales
- 4.6
- ROIC
- -521.5%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $2.16
- 52wk High
- $4.69
Growth
Revenue and earnings trend for BLRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BLRX
Is Biolinerx a good buy?
No. Biolinerx has poor quality and mixed momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Biolinerx is selling at a very high price.
What is the market capitalization of BLRX?
Biolinerx's market capitalization is $14.71M.
What is the P/E ratio for BLRX stock?
Biolinerx's current P/E ratio is -1.7.
What is the 52-week high for BLRX stock?
The 52-week high for Biolinerx is $4.69. The current close of $2.82 is 39.9% below that high.
What is the 52-week low for BLRX stock?
The 52-week low for Biolinerx is $2.16. The current close of $2.82 is 30.4% above that low.
Does BLRX stock pay dividends?
Biolinerx does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BLRX?
Biolinerx's Debt / Equity ratio is 0.54.